Clinical Trial Update: Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

View source ↗

Summary

A clinical trial update on validating a microRNA panel (mirPANC 2) to optimize treatment response in metastatic pancreatic cancer. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Benedito Mauro Rossi | Conditions: Pancreatic Cancer, Metastasis | Status: RECRUITING